ERAS
Erasca Inc
NASDAQ: ERAS · HEALTHCARE · BIOTECHNOLOGY
$9.11
-7.98% today
Updated 2026-04-29
Market cap
$6.68B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$1 – $24
Volume
6.9M
Erasca Inc (ERAS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-33.30%
ROA
-18.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-12.04M | — | — | — |
| 2020 | $0.00 | $-101.66M | — | — | — |
| 2021 | $0.00 | $-122.76M | — | — | — |
| 2022 | $0.00 | $-242.81M | — | — | — |
| 2023 | $0.00 | $-125.04M | — | — | — |
| 2024 | $0.00 | $-161.65M | — | — | — |
| 2025 | $0.00 | $-124.55M | — | — | — |